Literature DB >> 10896672

RhoA prenylation is required for promotion of cell growth and transformation and cytoskeleton organization but not for induction of serum response element transcription.

C Allal1, G Favre, B Couderc, S Salicio, S Sixou, A D Hamilton, S M Sebti, I Lajoie-Mazenc, A Pradines.   

Abstract

The importance of post-translational geranylgeranylation of the GTPase RhoA for its ability to induce cellular proliferation and malignant transformation is not well understood. In this manuscript we demonstrate that geranylgeranylation is required for the proper cellular localization of V14RhoA and for its ability to induce actin stress fiber and focal adhesion formation. Furthermore, V14RhoA geranylgeranylation was also required for suppressing p21(WAF) transcription, promoting cell cycle progression and cellular proliferation. The ability of V14RhoA to induce focus formation and enhance plating efficiency and oncogenic Ras anchorage-dependent growth was also dependent on its geranylgeranylation. The only biological activity of V14RhoA that was not dependent on its prenylation was its ability to induce serum response element transcriptional activity. Furthermore, we demonstrate that a farnesylated form of V14RhoA was also able to bind RhoGDI-1, was able to induce cytoskeleton organization, proliferation, and transformation, and was just as potent as geranylgeranylated V14RhoA at suppressing p21(WAF) transcriptional activity. These results demonstrate that RhoA geranylgeranylation is required for its biological activity and that the nature of the lipid modification is not critical.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10896672     DOI: 10.1074/jbc.M005264200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  25 in total

1.  Angiostatin effects on endothelial cells mediated by ceramide and RhoA.

Authors:  N Gupta; E Nodzenski; N N Khodarev; J Yu; L Khorasani; M A Beckett; D W Kufe; R R Weichselbaum
Journal:  EMBO Rep       Date:  2001-06       Impact factor: 8.807

2.  RhoA biological activity is dependent on prenylation but independent of specific isoprenoid modification.

Authors:  Patricia A Solski; Whitney Helms; Patricia J Keely; Lishan Su; Channing J Der
Journal:  Cell Growth Differ       Date:  2002-08

3.  Multiple sequence elements facilitate Chp Rho GTPase subcellular location, membrane association, and transforming activity.

Authors:  Emily J Chenette; Natalia Y Mitin; Channing J Der
Journal:  Mol Biol Cell       Date:  2006-04-26       Impact factor: 4.138

Review 4.  RHO GTPase signaling for axon extension: is prenylation important?

Authors:  Filsy Samuel; DiAnna L Hynds
Journal:  Mol Neurobiol       Date:  2010-09-28       Impact factor: 5.590

5.  Statins inhibit blastocyst formation by preventing geranylgeranylation.

Authors:  Vernadeth B Alarcon; Yusuke Marikawa
Journal:  Mol Hum Reprod       Date:  2016-02-07       Impact factor: 4.025

6.  Simvastatin promotes restoration of chondrocyte morphology and phenotype.

Authors:  Kenya Terabe; Nobunori Takahashi; Michelle Cobb; Emily B Askew; Cheryl B Knudson; Warren Knudson
Journal:  Arch Biochem Biophys       Date:  2019-02-15       Impact factor: 4.013

7.  Expansion of protein farnesyltransferase specificity using "tunable" active site interactions: development of bioengineered prenylation pathways.

Authors:  James L Hougland; Soumyashree A Gangopadhyay; Carol A Fierke
Journal:  J Biol Chem       Date:  2012-09-19       Impact factor: 5.157

8.  GEF mechanism revealed by the structure of SmgGDS-558 and farnesylated RhoA complex and its implication for a chaperone mechanism.

Authors:  Hikaru Shimizu; Sachiko Toma-Fukai; Kenji Kontani; Toshiaki Katada; Toshiyuki Shimizu
Journal:  Proc Natl Acad Sci U S A       Date:  2018-09-06       Impact factor: 11.205

9.  Effects of lovastatin on Rho isoform expression, activity, and association with guanine nucleotide dissociation inhibitors.

Authors:  Stephanie J Turner; Shunhui Zhuang; Tong Zhang; Gerry R Boss; Renate B Pilz
Journal:  Biochem Pharmacol       Date:  2007-09-01       Impact factor: 5.858

10.  Atorvastatin prevents RhoC isoprenylation, invasion, and metastasis in human melanoma cells.

Authors:  Eric A Collisson; Celina Kleer; Mei Wu; Abhijit De; Sanjiv S Gambhir; Sofia D Merajver; Michael S Kolodney
Journal:  Mol Cancer Ther       Date:  2003-10       Impact factor: 6.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.